Prospects for Anti-Biofilm Pharmaceuticals

Prospects for Anti-Biofilm Pharmaceuticals

This commentary highlights several avenues currently being pursued in research labs to the development of new anti-biofilm pharmaceuticals. There is a real need for alternative therapeutic modalities for treating the persistent infections that sometimes form on implanted medical devices or compromised niches within the body. Strategies being researched include discovering new antimicrobial agen...

The sociology of pharmaceuticals: progress and prospects.

This paper takes a critical look at progress and prospects regarding the sociology of pharmaceuticals over the years. Key themes examined include: (i) medicalisation and pharmaceuticalisation; (ii) regulation; (iii) consumption and consumerism; (iv) expectations and innovation. Papers in the monograph are also introduced and discussed in relation to these themes. The paper concludes with some f...

African Anti-Corruption Agencies: Challenges and Prospects

Corruption has become an issue of major political and economic relevance in recent years. This has led to a resurgence of interest in analyzing the phenomenon and the diverse forms that it assumes in developing politics with an expectation that democratization and economic liberation offer potential routes to dealing with the problem. Anti-corruption strategies range from institutional reforms ...

Future prospects for anti-cytokine treatment.

The era of anti-cytokine treatment in rheumatology has just begun. The first generation therapeutic agents, biological agents that block tumour necrosis factor alpha such as monoclonal antibodies or receptor Ig fusion proteins are safe and effective, and so this has generated much interest in how to increase the benefit or deliver it more cost effectively. This article provides a personal view ...

Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS